LeonaBio, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving LeonaBio, Inc. now
Current reporting with the operating signal separated from the noise.
LeonaBio, Inc.: LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
The story matters when it changes LeonaBio, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.LeonaBio, Inc.: LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
The story matters when it changes LeonaBio, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker "LONA”
The story matters when it changes LeonaBio, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest LONA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
LeonaBio, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →